1[1]Kreczko S,Lipska A,Wysocka J.Alfa-fetoprotein:diagnostic value in hepatic disorders[J].Pol Merkuriusz Lek,2000,8 (48):420-423.
2[2]Mita Y,Aoyagi Y,Suda T,et al.Plasma fucosyltransferase activity in patients with hepatocellular carcinoma with special reference to correlation with fucosylated species of alpha-fetoprotein[J].J Hepatol,2000,32:946 -954.
3[3]Peto J.Cancer epidemiology in the last century and the next decade[J].Nature,2001,411:390-395.
4[4]Shigetoshi F,Motohiko T,Seishi M,et al.Tumor markers in early diagnosis,follow-up and management of patients with hepatocellular carcinoma[J].Oncology,2002,62(S1):57-63.
5[5]Chu P G,Ishizawa S,Wu E,et al.Hepatocyte antigen as a marker of hepatocellular carcinoma:an immunohistochemical comparison to carcinoembryonic antigen,CD10,and alpha-fetoprotein[J].Am J Surg Pathol,2002,26 (8):978-88.
6[6]Yamamoto R,Azuma M,Hoshi N,et al.Lens culinaris agglutinin-reactive alpha-fetoprotein,an alternative variant to alpha-fetoprotein in prenatal screening for Down's syndrome[J].Hum Reprod,2001,16(11):2438-4424.
7[7]Yoshida S,Kurokohchi K,Arima K,et al.Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma[J].Int J Oncol,2002,20 (2):305 -309.
8[8]Kumada T,Nakano S,Takeda T,et al.Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma:special reference to imaging diagnosis[J].J Hepatol,1999,30(1):125-130.
9[9]Li D,Mallory T,Satomura S.AFP-L3:a new generation of tumor marker for hepatocellular carcinoma[J].Chin Clim Acta,2001,313(1-2):15-19.
10[10]Sarui H,Nakayama T,Takeda N,et al.Alpha-fetoprotein-producing male breast cancer accompanied with hepatocellular carcinoma:assessment by lectin-affinity profile[J].Am J Med Sci,2001,Dec,322(6):369-72.
3Hu Ko,kyulo NL,Lim N,et al.Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C,but not hepatocellular carcinoma.Am J Gastroenterol,2004,99(5):860-865.
4Taketa K,Kamakura K,Satomura S,et al.Lectin-dependent modulation of interaction between human alpha-fetoprotein andits monoclonal antibodies.Epitope mapping.Tumour Biol,1998,19(4):318-328.
5Li D,Mallory T,Satomura S.AFP-L3:a new generation of tumor marker for hepatocellular carcinoma.Clin Chim Acta,2001,313(1/2):15-19.
6Albanese E A,Bachl B C,Mulcahy G M.Analysis of alpha-fetoprotein heterogeneity by an improred crossed immunoaffinoelectrophoretic technique.Anal Biochem,1986,158(2):302-306.
7Kagebayashi C,Yamaguchi I,Akinaga A,et al.Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis.Anal Biochem,2009,388(2):306-311.
8Sato Y,Nakata K,Kato Y,et al.Early recognition of hepatocellular carcinoma based on altered profiles of alphafetoprotein.N Engl Med,1993,328(25):1802-1806.
9Shiraki K,Takase K,Tameda Y,et al.A clinical study of lectinreactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the fellow up of cirrhotic patients.Hepatology,1995,22(3):802.
10Oka H,Saito A,Ito K,et al.Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of lens culinaris agglutinin-reactive alphafetoprotein.Gastroenterol Hepatol,2001,16(12):1378-1383.
